UMBRELLA Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome Prediction
- Coordinator
- Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca, Spain
- Runs
- 1 October 2024 to 30 September 2029
- Status
- Running
- EU funding
- €14.8m
- Total cost
- €23.0m
- Partners
- 34 organisations in 12 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101172825
What the project is doing
In the project's own words, from its summary on CORDIS.
UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of care in terms of primary and secondary prevention, rapid access to treatments, early accurate diagnosis, stratification, management and real-time monitoring, therapeutic targets identification, and rehabilitation, recurrent stroke and related cardiovascular events. This innovative approach will transform healthcare systems by improving and harmonizing professionals' workflows in a more patient-centred, digitalized, and communicative manner.
UMBRELLA aims to revolutionize stroke management by implementing a comprehensive approach that addresses gaps along the whole continuum of the stroke care pathway. The key paradigm in the project is the multicentric, synergistic ""umbrella"" strategy for local data collection, harmonization, and standardization along the entire pre-, in-, and post-hospitalization pathway. By establishing specific common data models (CMDs) implemented in each of the 7 top-tier European clinical centres, UMBRELLA will create a federated data platform (U-platform) where Real World Data (RWD)-based AI algorithms can be locally created and validated, to advance personalised diagnosis, risk prediction, and treatment decisions in the acute and post-acute phases of stroke.
The algorithms will be then trained in a decentralized manner through a federated learning infrastructure (FL-platform), which preserve data security and privacy, avoiding data centralization or exchange across centres but fostering collective AI-models training. On the other hand, standardized stroke management protocols and procedures will be created and implemented across the participating centres, including the validated usage of advanced digital technologies as solutions to facilitate data collection, visualization, patient engagement, monitoring, outcomes integration, and decision-making across the whole stroke pathway.""
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Barcelona | Spain | Coordinator |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Stroke Alliance for Europe | Bruxelles / Brussel | Belgium | Participant |
| Actelion Pharmaceuticals Ltd | Allschwil | Switzerland | Associatedpartner |
| Organisation Europeenne Pour La Recherche Nucleaire | Geneve 23 | Switzerland | Participant |
| Universitat Basel | Basel | Switzerland | Associatedpartner |
| Universitatsspital Basel | Basel | Switzerland | Associatedpartner |
| Allm Emea GmbH | Dusseldorf | Germany | Participant |
| Penumbra Europe GmbH | Berlin | Germany | Participant |
| Siemens Healthineers AG | Forchheim | Germany | Participant |
| Universitaetsklinikum Hamburg-Eppendorf | Hamburg | Germany | Participant |
| Astrazeneca Farmaceutica Spain, S.a | Madrid | Spain | Participant |
| Daiichi Sankyo Espana SA | Pozuelo De Alarcon | Spain | Participant |
| Fundacio Eurecat | Cerdanyola Del Valles (Barcelona) | Spain | Participant |
| Fundacio Institut D'investigacio Biomedica De Bellvitge | L'Hospitalet De Llobregat | Spain | Third party |
| Janssen Cilag SA | Madrid | Spain | Participant |
| Nacar Estudio SL | Barcelona | Spain | Participant |
| Norahealth SL | Sant Cugat del Valles | Spain | Participant |
| Siemens Healthcare SL | Madrid | Spain | Associatedpartner |
| Teamit Institute S.l.u | Barcelona | Spain | Third party |
| Teamit Research S.l. | Barcelona | Spain | Participant |
| Philips France | Suresnes | France | Participant |
| Neuravi Limited | Galway | Ireland | Third party |
| Siemens Healthcare Private Limited | Vikhroli East | India | Associatedpartner |
| Fondazione Policlinico Universitario Agostino Gemelli Irccs | Roma | Italy | Participant |
| Eatris Eric | Amsterdam | Netherlands | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Nico-Lab BV | Amsterdam | Netherlands | Participant |
| Philips Medical Systems Nederland BV | Best | Netherlands | Participant |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| Trianect BV | Utrecht | Netherlands | Participant |
| Instituto Pedro Nunes Associacao Para a Inovacao E Desenvolvimento Em Ciencia E Tecnologia | Coimbra | Portugal | Third party |
| Siemens Healthcare Sro | Bratislava | Slovakia | Associatedpartner |
| Janssen Research & Development, LLC | Raritan | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI